Elevai Labs, Inc. (NASDAQ:ELAB) Short Interest Update

Elevai Labs, Inc. (NASDAQ:ELAB) was the recipient of a significant drop in short interest in March. As of March 15th, there was short interest totalling 50,500 shares, a drop of 76.0% from the February 29th total of 210,200 shares. Based on an average daily volume of 1,450,000 shares, the days-to-cover ratio is presently 0.0 days.

Elevai Labs Stock Performance

Shares of ELAB stock traded up $0.01 on Thursday, reaching $0.70. The company’s stock had a trading volume of 86,422 shares, compared to its average volume of 1,548,238. The stock’s fifty day simple moving average is $0.75. Elevai Labs has a 1 year low of $0.61 and a 1 year high of $4.24.

About Elevai Labs

Elevai Labs, Inc, a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc and changed its name to Elevai Labs, Inc in December 2021.